Alcohol Dependency Study: Combining Medication Treatment for Alcoholism
Public ClinicalTrials.gov record NCT00006205. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Combining Medications Treatment for Alcoholism
Study identification
- NCT ID
- NCT00006205
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bankole Johnson
- Other
- Enrollment
- 320 participants
Conditions and interventions
Conditions
Interventions
- ondansetron + cognitive behavioral therapy Drug
- topiramate + cognitive behavioral therapy Drug
- Placebo + cognitive behavioral therapy Drug
- ondansetron + topiramate + cognitive behavioral therapy Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2005
- Primary completion
- May 31, 2013
- Completion
- Nov 30, 2013
- Last update posted
- Mar 14, 2013
2005 – 2013
United States locations
- U.S. sites
- 2
- U.S. states
- 1
- U.S. cities
- 2
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Virginia Center for Addiction Research and Education | Charlottesville | Virginia | 22911 | Recruiting |
| University of Virginia Center for Addiction Research and Education | Richmond | Virginia | 23294 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00006205, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 14, 2013 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00006205 live on ClinicalTrials.gov.